Objectif
Brain conditions such as neurodegenerative diseases, stroke and traumatic injuries are a mayor burden in modern society. Because neural stem cells (NSCs) can differentiate into new neural cells including neurons, the regulation of their proliferation, differentiation and migration represent a promising regenerative/therapeutic strategy. The hypothesis of NanoStem project is that novel nanoparticles (NPs) combined with recent identified/developed pharmaceuticals can be an efficient approach to control the biological activity of NSCs. The scientific project is organized in three work packages (WP), each focusing on specific objectives and containing well-defined deliverables. WP1 will focus on the synthesis of the nanomaterials and the uploading of the therapeutics. WP2 will take the best nanoparticles and focus more on the evaluation of the permeation and efficacy of the formulations against NSCs. WP3 will focus on in vivo studies to evaluate the formulations developed to tackle the brain and to assess their toxicity. The project will train 14 ESRs in areas including organic and polymer chemistry, cell biology, pharmacology, neuroscience, nanobiotechnology and clinical sciences. The project will also provide a substantial training program in complementary skills, targeting both professional and personal development, and translation of research and entrepreneurship. The project brings together six academic partners, one hospital and two industrial teams as full partners, complemented by four associate partners, one of which is an industrial team, distributed over a total of seven European Union member states. The consortium brings together groups with a very interdisciplinary expertise ranging from nanoparticle synthesis and characterization, computational modeling, in vitro BBB models and BBB transport, neural stem cells, animal testing and clinical expertise.
Champ scientifique
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- natural scienceschemical sciencespolymer sciences
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesbasic medicineneurologystroke
- engineering and technologynanotechnologynano-materials
Programme(s)
Régime de financement
MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)Coordinateur
E1 4NS London
Royaume-Uni
Voir sur la carte
Participants (9)
3004 517 Coimbra
Voir sur la carte
62000 Arras
Voir sur la carte
17177 Stockholm
Voir sur la carte
3000-075 Coimbra
Voir sur la carte
85764 Neuherberg
Voir sur la carte
66802 Uberherrn
Voir sur la carte
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.
6020 Innsbruck
Voir sur la carte
Participation terminée
CV4 8UW COVENTRY
Voir sur la carte
B15 2TT Birmingham
Voir sur la carte
Partenaires (4)
Les organisations partenaires contribuent à la mise en œuvre de l’action, mais ne signent pas la convention de subvention.
59120 Loos
Voir sur la carte
Les organisations partenaires contribuent à la mise en œuvre de l’action, mais ne signent pas la convention de subvention.
35128 Padova
Voir sur la carte
Les organisations partenaires contribuent à la mise en œuvre de l’action, mais ne signent pas la convention de subvention.
66123 Saarbrucken
Voir sur la carte
Les organisations partenaires contribuent à la mise en œuvre de l’action, mais ne signent pas la convention de subvention.
3004-531 Coimbra
Voir sur la carte